Click on the name to know more
Frequently Asked Questions
Adapalene is a third-generation topical retinoid that selectively binds to retinoic acid receptor beta and gamma (RAR-beta/gamma), modulating cellular differentiation, keratinization, and inflammatory processes in the pilosebaceous unit. Unlike tretinoin (first-generation), Adapalene has greater receptor selectivity, which translates to comparable efficacy with significantly less skin irritation, erythema, and peeling. Its lipophilic nature allows better penetration into hair follicles, and it is photostable, unlike tretinoin which degrades under UV light. Adapalene is available in cream and gel formulations for once-daily application.
Minoxidil is a potassium channel opener originally developed as an oral antihypertensive. Its exact mechanism for promoting hair growth is not fully understood but is believed to involve multiple pathways: it acts as a vasodilator improving blood flow to hair follicles, prolongs the anagen (growth) phase of the hair cycle, stimulates follicular epithelial cell proliferation, and upregulates vascular endothelial growth factor (VEGF) and other growth factors. Minoxidil is most effective for androgenetic alopecia in both men and women when applied topically as a 2% or 5% solution or foam formulation.
For topical dermatological APIs, critical quality specifications include particle size distribution (which affects skin feel, absorption, and uniform dispersion in creams and gels), crystalline form and polymorphic purity (affecting chemical stability and release from the vehicle), heavy metals content (particularly for topically applied products), microbial limits per USP <61> and <62>, and residual solvent profiles. We ensure all dermatological APIs meet applicable pharmacopeial standards and provide compatibility data with common topical excipients when required for formulation development.
Yes, we supply dermatological APIs with specifications optimized for different topical vehicle systems including creams, ointments, gels, foams, and solutions. For an API like Adapalene intended for gel formulations, we provide specific particle size and crystalline form that ensures uniform dispersion and chemical stability in the gel matrix. For Terbinafine HCL used in cream and solution formulations, we can supply grades with appropriate solubility profiles for either oil-in-water emulsion systems or aqueous solution vehicles. We work with formulation scientists to define the optimal API specification for each vehicle system.
For dermatological product registrations, we provide comprehensive regulatory support including drug master files for US FDA submissions, ASMF or CEP for European registrations, and CTD-format dossiers for emerging markets. Our documentation includes batch analysis data, stability studies under ICH conditions, impurity qualification packages, elemental impurities risk assessment per ICH Q3D, residual solvent data, and GMP certificates. For topical products, we also provide data on particle size distribution, polymorphic form characterization by XRPD and DSC, and compatibility studies with common formulation excipients.
